| 2016 ESC/EAS guidelines for the management of dyslipidaemias AL Catapano, I Graham, G De Backer, O Wiklund, MJ Chapman, H Drexel, ... Polish Heart Journal (Kardiologia Polska) 74 (11), 1234-1318, 2016 | 4616 | 2016 |
| 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS) V Aboyans, JB Ricco, ML Bartelink, M Björck, M Brodmann, T Cohner, ... Kardiologia Polska (Polish Heart Journal) 75 (11), 1065-1160, 2017 | 4561* | 2017 |
| Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-κB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit … M Hernandez-Presa, C Bustos, M Ortego, J Tunon, G Renedo, ... Circulation 95 (6), 1532-1541, 1997 | 665 | 1997 |
| HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis C Bustos, MA Hernández-Presa, M Ortego, J Tuñón, L Ortega, F Pérez, ... Journal of the American College of Cardiology 32 (7), 2057-2064, 1998 | 639 | 1998 |
| Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial GG Schwartz, L Bessac, LG Berdan, DL Bhatt, V Bittner, R Diaz, ... American heart journal 168 (5), 682-689. e1, 2014 | 562 | 2014 |
| Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells M Ortego, C Bustos, MA Hernández-Presa, J Tuñón, C Dı́az, ... Atherosclerosis 147 (2), 253-261, 1999 | 531 | 1999 |
| Anti-inflammatory and immunomodulatory effects of statins LM Blanco-Colio, J Tuñón, JL Martín-Ventura, J Egido Kidney international 63 (1), 12-23, 2003 | 432 | 2003 |
| Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis JL Martin-Ventura, MC Duran, LM Blanco-Colio, O Meilhac, A Leclercq, ... Circulation 110 (15), 2216-2219, 2004 | 273 | 2004 |
| Diagnostic approaches for diabetic cardiomyopathy A Lorenzo-Almorós, J Tuñón, M Orejas, M Cortés, J Egido, Ó Lorenzo Cardiovascular diabetology 16, 1-14, 2017 | 249 | 2017 |
| Microvesicles in vascular homeostasis and diseases VC Ridger, CM Boulanger, A Angelillo-Scherrer, L Badimon, ... Thrombosis and haemostasis 117 (07), 1296-1316, 2017 | 248 | 2017 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 246 | 2019 |
| Novel methodologies for biomarker discovery in atherosclerosis IE Hoefer, S Steffens, M Ala-Korpela, M Bäck, L Badimon, ... European heart journal 36 (39), 2635-2642, 2015 | 216 | 2015 |
| Potential role of nuclear factor B in diabetic cardiomyopathy O Lorenzo, B Picatoste, S Ares-Carrasco, E Ramírez, J Egido, J Tuñón Mediators of inflammation 2011, 2011 | 209 | 2011 |
| Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells MA Hernández-Presa, JL Martın-Ventura, M Ortego, A Gómez-Hernández, ... Atherosclerosis 160 (1), 49-58, 2002 | 209 | 2002 |
| ACE inhibitor quinapril reduces the arterial expression of NF-κB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis MA Hernández-Presa, C Bustos, M Ortego, J Tuñón, L Ortega, J Egido The American journal of pathology 153 (6), 1825-1837, 1998 | 201 | 1998 |
| Alirocumab reduces total nonfatal cardiovascular and fatal events: the ODYSSEY OUTCOMES trial M Szarek, HD White, GG Schwartz, M Alings, DL Bhatt, VA Bittner, ... Journal of the American College of Cardiology 73 (4), 387-396, 2019 | 189 | 2019 |
| Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month JL Martín-Ventura, LM Blanco-Colio, A Gómez-Hernández, ... Stroke 36 (8), 1796-1800, 2005 | 178 | 2005 |
| Leukotriene B4 enhances the activity of nuclear factor-κB pathway through BLT1 and BLT2 receptors in atherosclerosis E Sánchez-Galán, A Gómez-Hernández, C Vidal, JL Martín-Ventura, ... Cardiovascular research 81 (1), 216-225, 2009 | 155 | 2009 |
| Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases A Lorenzo-Almorós, T Hang, C Peiró, L Soriano-Guillén, J Egido, J Tuñón, ... Cardiovascular diabetology 18, 1-16, 2019 | 139 | 2019 |
| NF-κB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability JL Martín-Ventura, LM Blanco-Colio, B Muñoz-García, ... Stroke 35 (2), 458-463, 2004 | 138 | 2004 |
Lorenzo O.Profesor Bioquímica (UAM)Verified email at uam.es
